Cytokeratin Fragments 21-1 Eia Kit
OVK is the FDA product code for Cytokeratin Fragments 21-1 Eia Kit, a class II device type, regulated under 21 CFR 866.6010. FDA's definition for this code reads: "The CYFRA 21-1 EIA kit is intended for the quantitative determination of soluble cytokeratin 19 fragments in human serum. The assay is to be used as an aid in monitoring disease progression during the course of disease and treatment in lung cancer patients. Serial testing for patient CYFRA 21-1 assay values should be...". As of , FDA records hold 3 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- OVK
- Device name
- Cytokeratin Fragments 21-1 Eia Kit
- FDA definition
- The CYFRA 21-1 EIA kit is intended for the quantitative determination of soluble cytokeratin 19 fragments in human serum. The assay is to be used as an aid in monitoring disease progression during the course of disease and treatment in lung cancer patients. Serial testing for patient CYFRA 21-1 assay values should be used in conjunction with other clinical methods used for monitoring lung cancer.
- Regulation
- 21 CFR 866.6010
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 3
- Ingested recalls
- 0
Clearances, product code OVK
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2011 | 1 |
| 2016 | 1 |
| 2025 | 1 |
Applicants with the most clearances
Product code OVK| Applicant | Clearances |
|---|---|
| Fujirebio Diagnostics, Inc. | 2 |
| Roche Diagnostics GmbH | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
